A prior abortion or miscarriage was not linked with an increased risk of developing pre- or postmenopausal breast cancer in a study published in Acta Obstetricia et Gynecologica Scandinavica
In the nationwide Finnish registry-based study, investigators analyzed data on 31,687 women with breast cancer diagnosed in 1972–2021 and 158,433 women without breast cancer.
The risk of breast cancer was the similar among women with a history of induced abortion and women with no history of abortion, both before and after 50 years of age. Risks were also similar among women with and without a past miscarriage.
In addition, breast cancer risks did not vary significantly by the number of abortions or miscarriages, nor by the time of first abortion or miscarriage.
“Miscarriage or induced abortion as potential risk factors for breast cancer has continued to raise concerns and has led to the spread of misinformation. In this study using high-quality Finnish registry data, we can reliably eliminate these concerns,” said corresponding author Oskari Heikinheimo, MD, PhD, of the University of Helsinki and Helsinki University Hospital. “Induced abortion or miscarriage are not risk factors for breast cancer, even if there are several of them. This information is important and reassuring for millions of women around the world.”
URL: https://onlinelibrary.wiley.com/doi/10.1111/aogs.70154
Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.
About the Journal
Published monthly, Acta Obstetricia et Gynecologica Scandinavica is an international women's health journal dedicated to providing the very latest information on the results of both clinical and research work from around the globe. The journal regularly publishes commentaries, reviews and original articles on a wide variety of topics, including obstetrics, gynecology, and female urology.
About Wiley
Wiley is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.